Advanced search

Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox I study (vol, 4, pg, 320, 2001).

(2002) CLIMACTERIC. 5(1).
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
NICKELSEN, T, G CREATSAS, and T RECHBERGER. 2002. “Differential Effects of Raloxifene and Continuous Combined Hormone Replacement Therapy on Biochemical Markers of Cardiovascular Risk: Results from the Euralox I Study (vol, 4, Pg, 320, 2001).” Climacteric.
APA
NICKELSEN, T., CREATSAS, G., & RECHBERGER, T. (2002). Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox I study (vol, 4, pg, 320, 2001). CLIMACTERIC.
Vancouver
1.
NICKELSEN T, CREATSAS G, RECHBERGER T. Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox I study (vol, 4, pg, 320, 2001). CLIMACTERIC. 2002.
MLA
NICKELSEN, T, G CREATSAS, and T RECHBERGER. “Differential Effects of Raloxifene and Continuous Combined Hormone Replacement Therapy on Biochemical Markers of Cardiovascular Risk: Results from the Euralox I Study (vol, 4, Pg, 320, 2001).” CLIMACTERIC 2002 : n. pag. Print.
@misc{141509,
  author       = {NICKELSEN, T and CREATSAS, G and RECHBERGER, T},
  issn         = {1369-7137},
  language     = {eng},
  number       = {1},
  pages        = {VI-VI},
  series       = {CLIMACTERIC},
  title        = {Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox I study (vol, 4, pg, 320, 2001).},
  volume       = {5},
  year         = {2002},
}

Web of Science
Times cited: